Best Weight-Loss Pills for Women: Prescription Options vs OTC Diet Pills

The short answer

There is no single "best" pill for every woman. The right medication depends on your body mass index, whether you have conditions like high blood pressure, diabetes, migraine, or depression, whether you could become pregnant, what your insurance covers, and how you tolerate side effects. A drug that suits one woman can be contraindicated for another, which is why every FDA-approved weight medication is prescription-only and requires a clinician's evaluation.

This page is informational and does not sell, prescribe, or dispense any medication. It explains what each oral option is, who the FDA labels and NIDDK say it may suit, the safety cautions that matter most for women, and how the real cost is structured, so you can have a sharper conversation with a licensed prescriber.

What "weight-loss pills" actually means for women

The phrase "weight-loss pills" covers three very different categories that should not be treated as interchangeable. The first is FDA-approved prescription medication taken by mouth, which has been tested for both effectiveness and safety and is available only through a licensed prescriber. The second is over-the-counter diet pills and dietary supplements, which are not reviewed by the FDA for effectiveness before they reach shelves. The third is the injectable GLP-1 medications people often lump in with pills; these are the most effective options today, but they are not pills at all.

For a woman searching for a pill, the practical reality is that the oral prescription options carry the evidence and the medical oversight, while OTC products carry marketing claims and, too often, hidden risks. NIDDK, part of the National Institutes of Health, publishes the reference list of prescription medications approved to treat overweight and obesity, and it is the most reliable starting point for what is genuinely approved.

It also matters that these medications are approved as an addition to reduced-calorie eating and increased physical activity, not as a replacement for them. The FDA labels frame every one of these drugs as part of a broader plan, which is why a prescriber will ask about diet, activity, sleep, and other medications before choosing one.

The FDA-approved oral options at a glance

The table below summarizes the oral prescription medications most relevant to women searching for weight-loss pills, based on what the FDA labels and NIDDK describe. It is a map for a conversation with a clinician, not a ranking, because the best fit depends entirely on your individual health profile.

Notice that only one row is an injectable's oral cousin: Rybelsus is a semaglutide pill, but its FDA approval is for type 2 diabetes, so using it purely for weight is off-label and should be discussed explicitly with a prescriber.

Phentermine: the short-term appetite suppressant

Phentermine is one of the oldest FDA-approved weight medications and works as a stimulant that suppresses appetite. Its approval is for short-term use, which is why clinicians typically frame it as a jump-start rather than a long-term therapy. NIDDK lists it among the medications used to treat overweight and obesity.

Because it is a sympathomimetic, phentermine can raise heart rate and blood pressure, so it is used cautiously or avoided in women with cardiovascular disease, uncontrolled high blood pressure, or hyperthyroidism, and it should not be used during pregnancy. It is also a controlled substance, which affects how it is prescribed and refilled.

For a woman whose main barrier is appetite and who needs a short, supervised push alongside diet and activity changes, phentermine can be a reasonable low-cost option. It is generally not the answer for someone looking for a medication to take for years, which is where the chronic-use combinations and GLP-1 medicines enter the picture.

Phentermine-topiramate (Qsymia): why pregnancy status is central

Qsymia combines phentermine with topiramate, a drug originally used for seizures and migraine that also reduces appetite. It is FDA-approved for chronic weight management, meaning it is intended for longer-term use than phentermine alone, and NIDDK lists it among approved obesity medications.

The single most important consideration for women is pregnancy. Topiramate can increase the risk of birth defects, including oral clefts, when taken during pregnancy, so Qsymia's use requires a negative pregnancy test before starting, monthly awareness of pregnancy status, and consistent, effective contraception. A woman who is pregnant, planning pregnancy, or unable to use reliable contraception is not a candidate for this medication.

Topiramate can also cause tingling in the hands and feet, changes in taste, and cognitive fog for some people, and it can affect the acid-base balance of the body. These are manageable for many women under supervision but make it a medication that genuinely requires an individualized prescriber discussion rather than a one-size decision.

Naltrexone-bupropion (Contrave): the craving and appetite pathway

Contrave pairs naltrexone, which blocks opioid receptors, with bupropion, an antidepressant that also reduces appetite and cravings. It is FDA-approved for chronic weight management and appears on NIDDK's list, and it is often considered for women whose eating is driven by cravings or reward-seeking rather than pure hunger.

The contraindications are specific and important. Contrave should not be used by women with a seizure disorder, uncontrolled high blood pressure, chronic opioid use, or an eating disorder history involving purging, and it cannot be combined with MAOI antidepressants. Because it contains bupropion, it also carries the class warning about suicidal thoughts and behavior associated with antidepressants, so mood should be monitored.

For a woman already taking bupropion for depression or smoking cessation, or one who cannot tolerate stimulants, the appetite-and-craving mechanism of Contrave can be attractive, but the medication interactions and mental-health monitoring make prescriber oversight essential.

Orlistat (Xenical and OTC Alli): blocking dietary fat

Orlistat works differently from the appetite-acting drugs: it blocks an enzyme in the gut so that some dietary fat is not absorbed and passes out of the body instead. Prescription-strength orlistat is sold as Xenical, and a lower-dose version, Alli, is available over the counter, making it the one genuinely evidence-based OTC option rather than an unproven supplement. NIDDK lists orlistat among approved medications.

Its side effects are largely gastrointestinal and depend on how much fat is eaten: oily stools, urgency, and gas are common, which pushes many users toward a lower-fat diet. Because it reduces fat absorption, orlistat can also lower the absorption of fat-soluble vitamins (A, D, E, and K) and certain medications, so a daily multivitamin taken at a different time is often recommended.

For women, one practical caution stands out: if orlistat causes severe diarrhea, the absorption of oral contraceptives could be reduced, so a backup method of contraception is advised during such episodes. Orlistat suits women who prefer a medication that does not act on the brain or heart, and who are willing to adjust dietary fat to manage its effects.

Where oral GLP-1 fits, and why the best-known drugs are injections

Many women arrive looking for a GLP-1 pill because they have heard about semaglutide and tirzepatide. The important clarification is that Wegovy (semaglutide) and Zepbound (tirzepatide), the two products FDA-approved specifically for chronic weight management, are injections, not pills. Ozempic (semaglutide) and Mounjaro (tirzepatide) are also injections and are FDA-approved for type 2 diabetes, so using either for weight alone is off-label.

The oral GLP-1 product that exists today is Rybelsus, a semaglutide tablet. But Rybelsus is FDA-approved for type 2 diabetes, not weight loss, so taking it purely to lose weight is off-label and should be an explicit, informed conversation with a prescriber rather than an assumed equivalent to Wegovy. It is a different product at a different dose and indication.

There is also a women-specific difference within the GLP-1 class that matters for contraception. Tirzepatide can reduce the effectiveness of oral contraceptives, and its label advises additional or non-oral birth control around starting and dose increases, while semaglutide does not carry that warning. This distinction can influence which medication a woman and her clinician choose.

Who qualifies: the BMI criteria on the FDA labels

The FDA labels for the chronic weight-management medications set consistent eligibility criteria based on body mass index. A woman generally qualifies with a BMI of 30 or higher, which is the threshold for obesity, or with a BMI of 27 or higher, the overweight range, when she also has at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol.

These thresholds are not arbitrary marketing numbers; they are printed in the Indications section of the FDA prescribing information for drugs like Wegovy and Zepbound, and comparable criteria apply to the oral chronic-use combinations. A prescriber uses them, along with your medical history, to decide whether medication is appropriate at all.

BMI is an imperfect screen, especially for women with more muscle mass or different fat distribution, so a good clinician reads it alongside waist measurement, blood pressure, blood sugar, and lipids. The label criteria set the door; your overall health picture decides which medication, if any, walks through it.

The reality of OTC diet pills and supplements

Over-the-counter diet pills marketed as fat burners, appetite suppressants, or metabolism boosters are, with the notable exception of OTC orlistat (Alli), dietary supplements rather than FDA-approved drugs. That means they are not reviewed by the FDA for effectiveness before sale, and their weight-loss evidence is generally weak, inconsistent, or absent.

Safety is a larger concern than most shoppers realize. The FDA has repeatedly found hidden, unapproved pharmaceutical ingredients in products sold as weight-loss supplements, including stimulants and prescription-only drugs that were never listed on the label. A product being available without a prescription is not evidence that it is safe or that it works.

The honest summary is that if a pill genuinely produced meaningful, reliable weight loss, it would almost certainly be regulated as a drug and require a prescription. Money spent on unproven OTC diet pills is usually better directed toward an evaluation with a clinician who can discuss the medications that actually have evidence behind them.

What weight-loss pills cost: structure, not a single number

Cost is where weight-loss content most often misleads, because a single quoted dollar figure rarely reflects what a specific woman will pay. What matters is the cost structure, and the same medication can sit at very different prices depending on which pathway you use. The table below lays out those pathways so you know which number applies to you and where to find the live figure.

Prices change frequently, and the only trustworthy source for a specific dollar amount is the manufacturer's own published coverage and savings page for that drug. For the injectable GLP-1 medications, for example, Lilly publishes Zepbound pricing and savings terms on its coverage-and-savings page and Novo Nordisk publishes Wegovy pricing through its save-on-Wegovy and NovoCare pages; check those directly rather than trusting a third-party quote.

For the older oral drugs like phentermine, Qsymia, Contrave, and orlistat, costs vary widely by pharmacy, dose, insurance tier, and whether a generic exists, so the practical move is to ask the prescribing clinic and your pharmacy for your actual price after coverage rather than relying on an advertised average.

Contraception, pregnancy, and menopause: the women-specific layer

Weight medication decisions carry considerations for women that generic guides skip. Contraception is one: tirzepatide can reduce oral contraceptive effectiveness, so its label advises a backup or non-oral method around starting and dose changes, whereas semaglutide carries no such warning. Orlistat can also reduce contraceptive absorption if it causes severe diarrhea. These are concrete reasons a prescriber asks what birth control you use before choosing a drug.

Pregnancy is a hard line. Weight-loss medications are not intended for use during pregnancy, and topiramate in Qsymia specifically carries a risk of birth defects, which is why reliable contraception and pregnancy testing accompany its use. A woman who is pregnant, trying to conceive, or breastfeeding should treat that status as decisive in the conversation.

Menopause adds another dimension. Many women notice weight and body-composition changes around the menopause transition, and questions about hormone therapy often arise alongside weight questions. Hormone therapy is a treatment for menopause symptoms, not a weight-loss drug, and the American College of Obstetricians and Gynecologists discusses its role and risks; weight medication and menopause management are separate decisions that a clinician can address together.

How to get prescription weight-loss pills legally online

Every FDA-approved weight-loss medication is prescription-only, so a legitimate telehealth path always includes a real medical evaluation before any prescription. That means sharing your health history, medications, and often your measurements and lab results, followed by a consult with a clinician licensed in your state who decides whether a medication is appropriate and which one.

If a prescription is written, it should be filled at a licensed pharmacy that dispenses an FDA-approved product. The presence of an intake form, a genuine prescriber review, and a state-licensed pharmacy are the markers of a legitimate service, not the absence of them.

Treat any website that offers to sell weight-loss drugs without a prescription, without a medical evaluation, or across a border with no oversight as a warning sign. That includes sellers pushing compounded semaglutide or tirzepatide as if they were the brand product; compounded versions are not FDA-approved, and the FDA has warned about unapproved and compounded GLP-1 products.

Choosing the right pill with your clinician

The most useful thing a woman can do before a consult is arrive with a clear picture: her BMI or measurements, her other health conditions, all current medications, her pregnancy and contraception situation, and what her eating patterns actually look like. Those inputs, matched against the cautions in this guide, narrow the realistic options quickly.

From there, the choice usually comes down to fit rather than a universal winner. Appetite-driven eating, craving-driven eating, cardiovascular history, seizure history, mood conditions, pregnancy plans, and insurance coverage each pull toward or away from a specific drug, and the strongest agents remain injections that a woman may or may not want to use.

Because this site does not prescribe or sell medication, the next step is to compare providers licensed in your state who can perform a proper evaluation, discuss the trade-offs above, and, if appropriate, prescribe an FDA-approved product through a licensed pharmacy.

Frequently asked questions

What is the best weight-loss pill for women?

There is no single best pill for every woman. Among FDA-approved oral options, NIDDK lists phentermine (short-term), phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), and orlistat (Xenical and OTC Alli). The best fit depends on your BMI, other health conditions, pregnancy and contraception status, tolerance for side effects, and insurance, which is why a licensed prescriber must choose it with you.

Are there FDA-approved weight-loss pills, or only injections?

There are FDA-approved oral weight-loss medications, including phentermine, Qsymia, Contrave, and orlistat. However, the two medications approved specifically for chronic weight management that produce the largest average weight loss, Wegovy (semaglutide) and Zepbound (tirzepatide), are injections rather than pills.

Can I get weight-loss pills over the counter?

The only FDA-approved over-the-counter weight-loss pill is lower-dose orlistat, sold as Alli. Other OTC diet pills are dietary supplements that are not FDA-approved for effectiveness and have weak evidence, and the FDA has repeatedly found hidden, unapproved drug ingredients in products marketed as weight-loss supplements.

Do weight-loss pills interfere with birth control?

Some can. Tirzepatide can reduce the effectiveness of oral contraceptives, and its label advises a backup or non-oral method around starting and dose increases; semaglutide does not carry that warning. Orlistat can also lower contraceptive absorption if it causes severe diarrhea, so backup contraception is advised during those episodes.

What BMI do I need to qualify for prescription weight-loss medication?

The FDA labels for chronic weight-management drugs set eligibility at a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol. A prescriber applies these thresholds alongside your full health history.

Is there a GLP-1 pill for weight loss?

The available oral GLP-1 product is Rybelsus, a semaglutide tablet, but it is FDA-approved for type 2 diabetes, not weight loss, so using it purely for weight is off-label. It is not the same product as Wegovy, which is the injectable semaglutide approved for chronic weight management.

Are compounded semaglutide or tirzepatide pills safe?

Compounded semaglutide and tirzepatide products are not FDA-approved, and the FDA has warned about unapproved and compounded GLP-1 products. Their quality, dose accuracy, and legality vary, and any seller offering them without a prescription and medical evaluation should be treated as a warning sign.

What about weight-loss pills during menopause?

Weight changes are common during the menopause transition, but hormone therapy is a treatment for menopause symptoms, not a weight-loss drug; ACOG discusses its role and risks. Weight medication and menopause management are separate decisions a clinician can address together during an evaluation.

Primary sources

1. NIDDK (NIH), Prescription Medications to Treat Overweight & Obesity.
2. FDA Prescribing Information, Wegovy (semaglutide) injection.
3. FDA Prescribing Information, Zepbound (tirzepatide) injection.
4. FDA Drugs@FDA approved-drug database (verify a product is FDA-approved).
5. Lilly, Zepbound coverage & savings.
6. Novo Nordisk, Save on Wegovy.
7. NovoCare, Wegovy cost & coverage.
8. ACOG, Hormone Therapy for Menopause (patient FAQ).